香港股市 已收市

中國醫藥 (600056.SS)

Shanghai - Shanghai 延遲價格。貨幣為 CNY。
加入追蹤清單
10.20+0.08 (+0.79%)
市場開市。 截至 11:29AM CST。

中國醫藥

No. 18 Guangming Zhongjie
Dongcheng District
Beijing 100061
China
86 10 6711 6688
https://www.meheco.com

版塊Healthcare
行業Medical Distribution
全職員工8,389

高階主管

名稱頭銜支付行使價出生年份
Ms. Huidong HuGM & Director1975
Mr. Jing Hua YuanBoard Secretary1978
Mr. Huibo ZhangAssistant to General Manager1983
Mr. Jiaqing HongDeputy General Manager1980
截止 為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 CNY。

描述

China Meheco Group Co., Ltd. engages in the pharmaceutical business in China and internationally. The company exports and imports natural medicines, pharmaceutical chemicals, medical equipment, and health products; produces and distributes pharmaceutical and health care products; and operates retail chain pharmacies. Its products include bulk pharmaceutical chemicals antibiotic fermentation and chemical synthesis tablets, injections, capsules, etc.; antibiotics; medicines for the treatment of cardio-cerebrovascular diseases, chronic diseases, and diabetes; antiviral; anti-infectious agents; gastrointestinal drugs; non-steroidal anti-inflammatory drugs; anti-allergic agents; specialty botanicals; western medicine preparations; Chinese patent medicines and herbal pieces; medical equipment and supplies; biological products; chemical raw materials; and nutritional and healthcare products. The company also plants, processes, warehouses, and transports ginseng, licorice, ephedra, rhubarb, rheum officinale, astragalus membranaceus, scutellaria baicalensis, fennel, and other herbs. China Meheco Group Co., Ltd. was founded in 1984 and is based in Beijing, China.

公司管治

截至 無 止,中國醫藥 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。